Question
Presented below are condensed financial statements adapted from those of two actual companies competing in the pharmaceutical industryJohnson and Johnson (J&J) and Pfizer, Inc. ($
Presented below are condensed financial statements adapted from those of two actual companies competing in the pharmaceutical industryJohnson and Johnson (J&J) and Pfizer, Inc. ($ in millions, except per share amounts).
Balance Sheets ($ in millions, except per share data) | |||||||
J&J | Pfizer | ||||||
Assets: | |||||||
Cash | $ | 12,005 | $ | 7,035 | |||
Short-term investments | 5,283 | 11,539 | |||||
Accounts receivable (net) | 7,879 | 10,080 | |||||
Inventories | 4,792 | 7,911 | |||||
Other current assets | 4,705 | 4,570 | |||||
Current assets | 34,664 | 41,135 | |||||
Property, plant, and equipment (net) | 13,050 | 21,491 | |||||
Intangibles and other assets | 17,726 | 71,051 | |||||
Total assets | $ | 65,440 | $ | 133,677 | |||
Liabilities and Shareholders' Equity: | |||||||
Accounts payable | $ | 6,181 | $ | 3,816 | |||
Short-term notes | 3,218 | 10,897 | |||||
Other current liabilities | 8,468 | 13,363 | |||||
Current liabilities | 17,867 | 28,076 | |||||
Long-term debt | 4,080 | 6,880 | |||||
Other long-term liabilities | 6,098 | 23,093 | |||||
Total liabilities | 28,045 | 58,049 | |||||
Capital stock (par and additional paid-in capital) | 4,470 | 68,400 | |||||
Retained earnings | 40,948 | 39,327 | |||||
Accumulated other comprehensive income (loss) | (770 | ) | 240 | ||||
Less: Treasury stock and other equity adjustments | (7,253 | ) | (32,339 | ) | |||
Total shareholders' equity | 37,395 | 75,628 | |||||
Total liabilities and shareholders' equity | $ | 65,440 | $ | 133,677 | |||
Income Statements | |||||||
Net sales | $ | 46,677 | $ | 50,003 | |||
Cost of goods sold | 13,310 | 10,966 | |||||
Gross profit | 33,367 | 39,037 | |||||
Operating expenses | 20,861 | 29,584 | |||||
Other (income) expensenet | (520 | ) | 3,745 | ||||
Income before taxes | 13,026 | 5,708 | |||||
Tax expense | 3,908 | 1,712 | |||||
Net income | $ | 9,118 | $ | 3,996 | * | ||
Basic net income per share | $ | 2.87 | $ | 0.67 | |||
* This is before income from discontinued operations. Evaluate and compare the two companies by responding to the following questions. Note: Because two-year comparative statements are not provided, you should use year-end balances in place of average balances as appropriate. Required: 1. For both companies, compute the ratios below. 2. Evaluate and compare the two companies.
* This is before income from discontinued operations. Evaluate and compare the two companies by responding to the following questions. Note: Because two-year comparative statements are not provided, you should use year-end balances in place of average balances as appropriate. Required: 1. For both companies, compute the ratios below 2. Evaluate and compare the two companies. Complete this question by entering your answers in the tabs below. Required 1 Required 2 For both companies, compute the ratios below. J&J Pfizer times times days days times times days days Receivables Turnover (#.##) Average Collection Period (#) Inventory Turnover (#.##) Average Days in Inventory (#) Profit Margin (#.##) % Asset Turnover (#.##) Return on Assets #.#)% Equity Multiplier (#.##) Return on Shareholders' Equity (#.#) % % times times (Required 1 Required 2 >
Step by Step Solution
There are 3 Steps involved in it
Step: 1
Get Instant Access to Expert-Tailored Solutions
See step-by-step solutions with expert insights and AI powered tools for academic success
Step: 2
Step: 3
Ace Your Homework with AI
Get the answers you need in no time with our AI-driven, step-by-step assistance
Get Started